Las Vegas Office: (725) 900-9000 Washington Office: (360) 200-0000
Van Law Firm
  • About Us
    • Attorneys
    • Sandy Van
    • Angela J. Campos
    • Burke Huber
    • Annual Scholarship
    • Refer Clients
  • Practice Areas
    • Motor Vehicle Accident
    • Slip and Fall
    • Wrongful Death
    • Casino Injury
    • Mass Torts
    • Uninsured And Underinsured Accidents
    • Personal Injury
    • Product Liability
    • Bad Faith Insurance Claims
    • Camp Lejeune Lawsuit
    • Nursing Home Abuse
    • Las Vegas Defective Drugs and Medical Devices
    • Sexual Abuse
    • Truck Accident
    • Swimming Pool Injury
  • Testimonials
  • Blogs
    • FAQs
    • Videos
  • Contact Us
  • Locations
    • Las Vegas Office
    • Washington Office
    • View All Locatoins
Get My Free Consultation
(725) 900-9000

Home » Blogs » Personal Injury » The Dangers of Elmiron and Retinal Damage: What Do You Need to Know?

The Dangers of Elmiron and Retinal Damage: What Do You Need to Know?

We’ve all seen the cross-legged, back-and-forth dance of someone who just has to go pee. Conversely, all of us have felt the discomfort of a full bladder when you’re seemingly miles away from the nearest bathroom. For those who have been diagnosed with interstitial cystitis (IC), this feeling is all too common. 

For a free legal consultation, call (725) 900-9000

For the majority of IC patients, the quickest form of treatment is a prescription for Elmiron. The pain-relieving drug is currently the only approved oral medicine for IC, and comes with relatively fleeting side effects– nausea, diarrhea, dizziness, etc. 

But what about permanent damage to your retina and vision loss? For the first 24 years of the drug’s sales, this warning was nowhere to be found. Now, as longtime users are facing serious complications, many could be entitled to compensation. 

What is Interstitial Cystitis?

Interstitial Cystitis (IC), also known as painful bladder syndrome, is a chronic condition which, as you might suspect, causes bladder pain and discomfort. Other symptoms can include:

  • Pelvic pain
  • Frequent urination
  • Pain or discomfort during sexual intercourse

Click to contact our personal injury lawyers today

These symptoms vary greatly between patients, ranging from mild to severe– they can also change over time, with periodical lulls and flare-ups. The condition is considered to be relatively common, with over a million cases in the US. Women are diagnosed about twice as often than men, and most patients are aged 30 and older. 

Complete a Free Case Evaluation form now

There is currently no known definitive cure for IC, and treatments are wide-ranging; non-invasive methods include special diets and therapies, and prescription treatments involve antihistamines, antidepressants, and most notably pentosan polysulfate sodium (PPS). PPS is prescribed in the form of the drug Elmiron. 

What is Elmiron?

Elmiron is by far the most common medical treatment for IC, as it’s the only oral drug approved for it, and it is not available in a generic form. Essentially, it works by forming a protective coating on the inner lining of the bladder to help protect against inflammation from irritants in one’s urine. It doesn’t effectively cure the condition, but steady users can see some improvement in pain relief over time. 

The drug, which is manufactured by Janssen Pharmaceuticals, was approved by the FDA in 1996 under the Orphan Drug Act, which gives special incentives to manufacturers of drugs that treat rare diseases. In the decades since its release, because of Elmiron’s accessibility and its monopoly on IC medications, it is believed that hundreds of thousands of patients have been exposed to the drug. 

Issues With Elmiron and Why Patients are Suing: A Brief Timeline

There were little to no issues in the first 20-plus years of the drug’s sales, until 2018, when a groundbreaking study from Emery Eye Center in Atlanta posited that prolonged exposure to PPS (Elmiron) can lead to a unique form of maculopathy. 

Maculopathy is a progressive condition which affects a specific part of your retina called the macula– the part of your eye where vision is keenest. Patients with maculopathy typically experience the following:  

  • Blurry or dark spots in the center of your vision
  • Difficulty adjusting to low-light environments
  • Difficulty reading or focusing on object details
  • Distorted objects and lines

The discovery of maculopathy in Elmiron users was important for two reasons: the first is that potential eye damage was never listed on Elmiron’s possible side effects; the second was that all of the studied patients tested negative for other possible causes of maculopathy. Essentially, it verified that extensive Elmiron use was the root cause. 

After the publication of Emery’s study, researchers at Kaiser Permanente in California were frightened by the results and decided to investigate their own patient population. Their findings were all the more damning– a report in January of 2020 revealed that for patients who had ingested over 1,500 grams of Elmiron (about 15 years’ worth), a whopping 42 percent had developed definite signs of drug toxicity. 

In response to these findings, the FDA announced on June 16th, 2020 that Janssen Pharmaceuticals had made changes to the Elmiron label to include “pigmentary changes in the retina” in the “Warnings and Precautions” and “Adverse Reactions” sections of the packaging. Many longtime users have begun to file lawsuits against Janssen for their negligence in warning patients of potential risks, and for only acknowledging hazards after decades of production. 

Am I Eligible for an Elmiron Lawsuit?

As of May 2021, Elmiron litigation has advanced to the point where certain case criteria are being established. All potential Elmiron claimants should note the following: 

  • Documented Use History: Claimants should be able to demonstrate prolonged use of Elmiron, either through prescription records or otherwise. Generally, at least one year of use is ideal for a strong claim, but this is not required. 
  • Ocular Difficulties: Next, the plaintiff must show that Elmiron use was detrimental to the health of their eyes and vision. This can be presented in multiple ways, such as:
  • Macular degeneration (MD)
  • Age-related macular degeneration (ARMD)
  • Retinal Maculopathy
  • Retinal Pigmentary Endothelium Injury (RPE)
  • Other types of maculopathy or retinal damage

Without a confirmed diagnosis, clients should have at least consulted a physician for symptoms such as general vision loss, trouble reading or focusing, problems adjusting to low light, or glare or light sensitivity. Conversely, a case will be considered especially strong if the claimant has an actual diagnosis that is confirmed by Fundus Autofluorescence Imaging (FAF), Near-infrared Reflectance (NIR), Optical Coherence Tomography (OCT), or Heidelberg Multicolor. 

Contact Trusted Elmiron Attorneys

If you’re struggling with retinal and vision damage after prolonged exposure to Elmiron, call the experienced Elmiron attorneys from Van Law Firm now for a free and confidential consultation to discuss the eligibility of your claim. 

Contact our office nearest you today to see why we have a verified 5-star rating across all digital review platforms. With tens of millions of dollars collected for our clients to date, it’s no secret that we are one of the most respected and fastest-growing law firms in the country.

We’ve all seen the cross-legged, back-and-forth dance of someone who just has to go pee. Conversely, all of us have felt the discomfort of a full bladder when you’re seemingly miles away from the nearest bathroom. For those who have been diagnosed with interstitial cystitis (IC), this feeling is all too common. 

For the majority of IC patients, the quickest form of treatment is a prescription for Elmiron. The pain-relieving drug is currently the only approved oral medicine for IC, and comes with relatively fleeting side effects– nausea, diarrhea, dizziness, etc. 

But what about permanent damage to your retina and vision loss? For the first 24 years of the drug’s sales, this warning was nowhere to be found. Now, as longtime users are facing serious complications, many could be entitled to compensation. 

What is Interstitial Cystitis?

Interstitial Cystitis (IC), also known as painful bladder syndrome, is a chronic condition which, as you might suspect, causes bladder pain and discomfort. Other symptoms can include:

  • Pelvic pain
  • Frequent urination
  • Pain or discomfort during sexual intercourse

These symptoms vary greatly between patients, ranging from mild to severe– they can also change over time, with periodical lulls and flare-ups. The condition is considered to be relatively common, with over a million cases in the US. Women are diagnosed about twice as often than men, and most patients are aged 30 and older. 

There is currently no known definitive cure for IC, and treatments are wide-ranging; non-invasive methods include special diets and therapies, and prescription treatments involve antihistamines, antidepressants, and most notably pentosan polysulfate sodium (PPS). PPS is prescribed in the form of the drug Elmiron. 

What is Elmiron?

Elmiron is by far the most common medical treatment for IC, as it’s the only oral drug approved for it, and it is not available in a generic form. Essentially, it works by forming a protective coating on the inner lining of the bladder to help protect against inflammation from irritants in one’s urine. It doesn’t effectively cure the condition, but steady users can see some improvement in pain relief over time. 

The drug, which is manufactured by Janssen Pharmaceuticals, was approved by the FDA in 1996 under the Orphan Drug Act, which gives special incentives to manufacturers of drugs that treat rare diseases. In the decades since its release, because of Elmiron’s accessibility and its monopoly on IC medications, it is believed that hundreds of thousands of patients have been exposed to the drug. 

Issues With Elmiron and Why Patients are Suing: A Brief Timeline

There were little to no issues in the first 20-plus years of the drug’s sales, until 2018, when a groundbreaking study from Emery Eye Center in Atlanta posited that prolonged exposure to PPS (Elmiron) can lead to a unique form of maculopathy. 

Maculopathy is a progressive condition that affects a specific part of your retina called the macula– the part of your eye where vision is keenest. Patients with maculopathy typically experience the following:  

  • Blurry or dark spots in the center of your vision
  • Difficulty adjusting to low-light environments
  • Difficulty reading or focusing on object details
  • Distorted objects and lines

The discovery of maculopathy in Elmiron users was important for two reasons: the first is that potential eye damage was never listed on Elmiron’s possible side effects; the second was that all of the studied patients tested negative for other possible causes of maculopathy. Essentially, it verified that extensive Elmiron use was the root cause. 

After the publication of Emery’s study, researchers at Kaiser Permanente in California were frightened by the results and decided to investigate their own patient population. Their findings were all the more damning– a report in January of 2020 revealed that for patients who had ingested over 1,500 grams of Elmiron (about 15 years’ worth), a whopping 42 percent had developed definite signs of drug toxicity. 

In response to these findings, the FDA announced on June 16th, 2020 that Janssen Pharmaceuticals had made changes to the Elmiron label to include “pigmentary changes in the retina” in the “Warnings and Precautions” and “Adverse Reactions” sections of the packaging. Many longtime users have begun to file lawsuits against Janssen for their negligence in warning patients of potential risks, and for only acknowledging hazards after decades of production. 

Am I Eligible for an Elmiron Lawsuit?

As of May 2021, Elmiron litigation has advanced to the point where certain case criteria are being established. All potential Elmiron claimants should note the following: 

  • Documented Use History: Claimants should be able to demonstrate prolonged use of Elmiron, either through prescription records or otherwise. Generally, at least one year of use is ideal for a strong claim, but this is not required. 
  • Ocular Difficulties: Next, the plaintiff must show that Elmiron use was detrimental to the health of their eyes and vision. This can be presented in multiple ways, such as:
  • Macular degeneration (MD)
  • Age-related macular degeneration (ARMD)
  • Retinal Maculopathy
  • Retinal Pigmentary Endothelium Injury (RPE)
  • Other types of maculopathy or retinal damage

Without a confirmed diagnosis, clients should have at least consulted a physician for symptoms such as general vision loss, trouble reading or focusing, problems adjusting to low light, or glare or light sensitivity. Conversely, a case will be considered especially strong if the claimant has an actual diagnosis that is confirmed by Fundus Autofluorescence Imaging (FAF), Near-infrared Reflectance (NIR), Optical Coherence Tomography (OCT), or Heidelberg Multicolor. 

Contact Trusted Elmiron Attorneys

If you’re struggling with retinal and vision damage after prolonged exposure to Elmiron, call the experienced Elmiron attorneys from Van Law Firm now for a free and confidential consultation to discuss the eligibility of your claim. 

Contact our office nearest you today to see why we have a verified 5-star rating across all digital review platforms. With tens of millions of dollars collected for our clients to date, it’s no secret that we are one of the most respected and fastest-growing law firms in the country.

No obligation consultations are always free.

Let Us Help You! Call Now: (725) 900-9000
We are available 24/7

Recent Posts

  • Breaking Down the Insulin Pricing Scheme Puzzle
  • EzriCare Eye Drop Recall
  • Search Engine Optimization and AI Bots
  • A Day of Justice for Sexual Assault Survivors
  • Tesla Auto Accidents

Categories

  • Accidents & Lawsuits
  • Artificial Intelligence
  • Auto Accidents
  • Baby Formula Lawsuits
  • Bankruptcy
  • Burn Injuries
  • Bus Acciidents
  • Camp Lejeune
  • Defective Medical Devices
  • Drowning Accidents
  • Drunk Driving Accidents
  • Elmiron
  • Heating Pad Injuries
  • Insurance
  • Legal Alerts
  • Mass Torts
  • Medical Malpractice
  • Motorcycle Accidents
  • News and Updates
  • Nursing Home Abuse
  • Paraquat Lawsuits
  • Park Accidents
  • Pedestrian Accidents
  • Personal Injury
  • Premises Liability
  • Product Liability
  • Sexual Abuse
  • Sexual Assault
  • Slip and Fall Accidents
  • Swimming Pool Accidents
  • Swimming Pool Injuries
  • Traumatic Brain Injuries
  • Truck Accidents
  • Truvada
  • Whiplash Injury
  • Workers Compensation
  • Wrongful Death
  • Zantac

FAQs

What is a Short Sale?

faq thumb

Buying a home After a Short Sale

faq thumb

What is a Deficiency and Why Should I Be Worried?

faq thumb

Find Yourself a Passionate Lawyer Now!

  • Bellingham Personal Injury Lawyer Near Me
  • Boulder City Personal Injury Lawyer Near Me
  • Centennial Hills Personal Injury Lawyer Near Me
  • Henderson Personal Injury Lawyer Near Me
  • Lakewood Personal Injury Lawyer Near Me
  • Las Vegas Personal Injury Lawyer Near Me
  • Nationwide Personal Injury Lawyer Near Me
  • Washington Personal Injury Lawyer Near Me
  • Yakima Personal Injury Lawyer Near Me
  • Seattle Personal Injury Lawyer Near Me

Personal Injury Blog Posts:

INSTALLATION OF POSITIVE TRAIN CONTROL TECHNOLOGY INSTALLATION OF POSITIVE TRAIN CONTROL TECHNOLOGY

Railroads are required to install positive train control technology but a report by the FRA shows that while some railroads have made significant progress, many freight and commuter railroads are no...

KIDS WITH GUNS: WHO IS LIABLE? KIDS WITH GUNS: WHO IS LIABLE?

Gun owners may be liable for the injuries and deaths that are caused when kids accidentally shoot someone. Of the 265 kid-with-gun shootings reported in 2015, 83 resulted in a death. Forty-one young...

CUMULATIVE TRAUMA ON THE TRACKS CUMULATIVE TRAUMA ON THE TRACKS

Cumulative trauma injuries accumulate over time and often result in severe injuries for railroad workers. Railroad workers operate in hostile environments where life-changing accidents are common, b...

E-SCOOTER DANGERS: THE COST OF CONVENIENCE E-SCOOTER DANGERS: THE COST OF CONVENIENCE

E-scooters are becoming increasingly popular across the United States and riders need to be aware of the dangers involved. These motorized vehicles are a top transportation choice among commuters in...

  • Las Vegas, NV
    1290 S Jones Blvd
    Las Vegas, NV 89147

    Get Directions
  • Lakewood, WA
    9311 Bridgeport Way SW
    Lakewood WA 98499

    Get Directions
  • Yakima, WA
    32 N 3rd St STE 304
    Yakima, WA 98901

    Get Directions
Van Law Firm

Van law firm is a personal injury law firm that represents individuals injured by motor vehicle accidents in Las Vegas, Henderson, and throughout Washington. We also represent workers’ compensation cases and people who have been hurt by defective drugs like Zantac, medical devices, and products nationwide.

Contact Info

1290 S Jones Blvd
Las Vegas, NV 89146
(725) 900-9000 (702) 800-4662 Get Map & Directions
9311 Bridgeport Way SW
Lakewood, WA 98499
(360) 200-0000 (360) 208-0248 Get Map & Directions
32 N 3rd St STE 304
Yakima, WA 98901
(509) 505-1000 (509) 272-0300 Get Map & Directions

Practice Areas

  • MOTOR VEHICLE ACCIDENT
  • PERSONAL INJURY
  • WRONGFUL DEATH
  • PRODUCT LIABILITY
  • BAD FAITH INSURANCE CLAIMS
  • UNINSURED AND UNDERINSURED ACCIDENTS
  • NURSING HOME ABUSE
Expertise best personal injury attorney award America's Fastest growing private companies award Honoree Ribbon

Privacy Policy © Copyright 2023 Van Law Firm

Please consult an attorney for advice about your unique and individual situation. This website and its information is not legal advice, nor is it intended to be. Calling our firm does not create an attorney-client relationship. Until an attorney-client relationship is established, please withhold from sending any confidential information.